PT-NANBH
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1 (NCT02485080) | Stanford University | 2015-09-01 |
| Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6 (NCT02480166) | Stanford University | 2015-06-01 |
Track PT-NANBH automatically
Every clearance here is in the API, with alerts when new ones post.